Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds. On ...
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.
The gene editing tool known as CRISPR-Cas9 is changing what’s possible for treating a wide range of diseases caused by ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...
Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced the appointment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results